When the whole sample of patients was stratified by NAFLD status at baseline, patients with NAFLD (n = 109) were more likely to be male (56% vs. 34%), younger (80±9 vs. 84±9 years) and had higher BMI (28.4±7 vs. 25.8±5 kg/m2), higher serum triglycerides (1.19±0.5 vs. 0.95±0.4 mmol/l) and lower values of AST/ALT ratio and eGFRCKD-EPI compared to those without NAFLD (n = 103). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.